A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe.
Mazhindu T, Nyangwara VA, Borok MZ, Masimirembwa C, Flaig T, Campbell TB, Ndlovu N · S Afr Med J (2026)
Zimbabwe · DOI: 10.7196/SAMJ.2026.v116i5.3655
Early-onset chronic progressive cardiotoxicity (ECPC) is a significant cause of morbidity and mortality among patients who receive doxorubicin-based chemotherapy for breast cancer.
To establish incidence of ECPC in black Zimbabwean women with breast cancer treated with doxorubicin and the resultant survival, and to describe the pharmacogenomic biomarkers' association with prognosis.
A prospective observational study was conducted in Zimbabwe with 50 participants who received doxorubicin-based treatment and were actively followed up to 12 months, with 3-monthly echocardiography and vital status determined at 60 months for all-cause mortality analysis.
ECPC was observed in 10% of participants. Median survival for participants who developed ECPC and those without was 11.9 v. 40.8 months. Participants with ECPC had 5-year overall survival (OS) of 0% v. 42% (hazard ratio (HR) 4.19, 95% confidence interval (CI) 1.27 - 13.79; p=0.018) for participants with no ECPC recorded. Median survival was significantly shorter for patients on calcium channel blockers (p=0.01). Cardiotoxicity, pre-existing hypertension and histological grade showed no significant association. Using multivariate analysis, poor OS was observed with ECPC (HR 4.19, 95% CI 1.27 - 13.79; p=0.018) and calcium channel blocker use (HR 2.38, 95% CI 1.07 - 5.32; p=0.034); no association was observed with pharmacogenomic biomarker risk categorisation based on SLC28A3, UGT1A6 and RARG (HR 1.39, 95% CI 0.46 - 4.25; p=0.561).
Breast cancer patients with doxorubicin-induced ECPC had poorer OS. The risk of doxorubicin cardiotoxicity and poor survival could not be explained using SLC28A3-scoring pharmacogenomic profile. Breast cancer therapies with lower cardiotoxicity are needed in Zimbabwe and other low-resource settings.
Intestinal Permeability Is Associated with Mortality and Readmission in Children Hospitalized with Severe Acute Malnutrition.
Sturgeon JP, Chasekwa B, Tome J, Dumbura C, Majo FD, Ngosa D, Mutasa K, Besa E, Nathoo KJ, Bourke CD, Haider T, Ntozini R, Bwakura-Dangarembizi M, Amadi B, Kelly P, Prendergast AJ · J Nutr (2026)
Zimbabwe · DOI: 10.1016/j.tjnut.2026.101655
Severe acute malnutrition (SAM) is the most critical form of undernutrition, associated with high inpatient and postdischarge mortality. It is hypothesized that malnutrition enteropathy contributes to systemic inflammation by allowing translocation of intestinal pathogen-associated molecular patterns across the damaged epithelium.
Assess intestinal permeability, markers of bacterial translocation, and correlate these with inflammatory markers in children admitted with SAM and during 1 y after discharge.
In a substudy of the longitudinal Health Outcomes, Pathogenesis and Epidemiology of Severe Acute Malnutrition observational study, we recruited 264 children with complicated SAM on admission to hospital at 3 centers in Zimbabwe and Zambia. We measured gut permeability by urinary lactulose:mannitol ratio (LMR); plasma lipopolysaccharide (LPS) using the limulus amoebocyte lysate assay; and plasma inflammatory biomarkers by enzyme-linked immunosorbent assay and Luminex, at admission, discharge, 12- and 48-wk postdischarge. Values were compared with 173 adequately nourished community controls. Data were analyzed using mixed effects models for longitudinal data, regression for associations between groups, and Cox proportional hazards models for survival.
Gut permeability, as measured by LMR, was 2.5-fold higher in children with SAM compared with community controls [95% confidence interval (CI): 1.4, 4.5], and only resolved by 48-wk postdischarge. Higher inpatient gut permeability was associated with increased risk of death or readmission over the following year [hazard ratio 6.14 (95% CI: 1.03, 36.8) per 10-fold increase in LMR]. Children with high gut permeability had higher levels of the intestinal biomarker glucagon-like peptide-2 and lower L-selectin. Children with higher plasma LPS had independently higher concentrations of circulating inflammatory markers [tumor necrosis factor-α, interleukin (IL)-6, IL-1ra, C-reactive protein, IL-8, chemokine ligand 3, and chemokine ligand 4].
Collectively, these results highlight the central role of the gut in children with SAM. Malnutrition enteropathy may represent a suitable target for therapeutic interventions to improve clinical outcomes in this high-risk population.
Aberrant polyploidization pathways in megakaryocytes as therapeutic targets in leukemia.
Obeagu EI · Ann Med Surg (Lond) (2026)
Zimbabwe · DOI: 10.1097/MS9.0000000000004891
Megakaryocyte polyploidization is a specialized process essential for platelet production, orchestrated by tightly regulated transcriptional programs, cell-cycle control, and signaling pathways. Disruption of this process - characterized by incomplete endomitosis, low ploidy, and maturation arrest - contributes to leukemic transformation, particularly in acute megakaryoblastic leukemia and related myeloid malignancies. Aberrant polyploidization arises from transcription factor dysregulation, cell-cycle abnormalities, hyperactive proliferative signaling, microenvironmental alterations, and genomic instability. These defects collectively promote proliferation, differentiation arrest, and malignant expansion of megakaryocytic progenitors. Therapeutic strategies targeting these pathways, including modulation of transcription factors, restoration of endomitotic progression, inhibition of JAK-STAT and RAS/MAPK signaling, epigenetic reprogramming, and niche-directed interventions, offer promising avenues to suppress leukemic growth and restore normal maturation. Understanding aberrant polyploidization as a driver of leukemogenesis provides a framework for developing precision therapies in megakaryocytic leukemia.
Cytogenetic alterations and coagulopathy in breast cancer patients: molecular mechanisms and clinical implications.
Obeagu EI · Ann Med Surg (Lond) (2026)
Zimbabwe · DOI: 10.1097/MS9.0000000000004893
Breast cancer is characterized by diverse cytogenetic alterations that play a pivotal role in tumor initiation, progression, and therapeutic resistance. These chromosomal abnormalities, including gains, losses, and structural rearrangements, contribute to genomic instability and influence cellular behavior in ways that extend beyond tumor growth. One significant but often overlooked consequence of these cytogenetic changes is their impact on the coagulation system, leading to a hypercoagulable state and increasing the risk of thrombosis in breast cancer patients. Emerging evidence links specific cytogenetic aberrations to the dysregulation of coagulation pathways through molecular mechanisms such as upregulation of tissue factor expression, enhanced release of procoagulant microparticles, and modulation of platelet and endothelial cell activation. These processes collectively foster a prothrombotic environment, exacerbating complications like venous thromboembolism and disseminated intravascular coagulation, which significantly affect patient morbidity and mortality. Moreover, the interplay between chromosomal instability and coagulation dysregulation may also influence tumor progression and metastasis.
Reduced Genetic Load and Inbreeding in Reintroduced African Wild Dogs Reflect the Benefits of Admixture.
Tensen L, Wang X, Watermeyer J, du Plessis C · Mol Ecol (2026)
Zimbabwe · DOI: 10.1111/mec.70424
Conservation translocations have become important assets in saving African wild dogs (Lycaon pictus) from local extinction, which have declined drastically due to anthropogenic pressures. In South Africa, wild dogs were eradicated except for a small, isolated population remaining in Kruger National Park. Due to reintroductions into private reserves, the country now holds a viable metapopulation of over 150 individuals that is used as a donor to repopulate other countries in southern Africa. This Range Expansion Project allows a unique opportunity to quantify the genomic effect of founder events, population isolation and conservation translocations. For this purpose, we harvested 30 whole genomes of wild dogs from Kruger, private reserves and outside protected areas. Demographic reconstructions indicate that populations were historically large (10,000-40,000 individuals) but began declining gradually ~500-100 kya, coinciding with Mid-Pleistocene climate shifts, followed by a sharp collapse ~2-0.8 kya. The Kruger population showed a substantially higher genetic load and a greater extent of runs of homozygosity (ROHs), indicating that its reduced genetic variation is driven primarily by inbreeding rather than demographic history. In contrast, reintroduced populations in private reserves exhibited the highest genetic diversity and the lowest genetic load. The short ROHs and close genetic affinity to an individual from Kenya support the view that wild dogs historically functioned as a largely panmictic species, and that reconnecting isolated populations can restore evolutionary potential. The absence of drift and relaxed selection implies that genetic resilience can be restored through population admixture, providing valuable guidance for managing threatened species.
The impact of interventions to modify antibiotic use in children with suspected infections in ambulatory healthcare settings in LMICs: a systematic review.
Hardman JS, Chareka G, O'Mahony E, Murongazvombo AS, Chew C, Ray SC, Yeung S, Fitzgerald FC · JAC Antimicrob Resist (2026)
Zimbabwe · DOI: 10.1093/jacamr/dlag109
Antimicrobial resistance (AMR) is a growing threat to child health in low- and middle-income countries (LMICs), where inadequate antibiotic access frequently causes morbidity and mortality. We sought to identify effective interventions to optimize antibiotic use in children with suspected infections in LMIC ambulatory healthcare settings.
MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Infectious Disease Group Specialized Register, Web of Science, PsycInfo, WHO library database (WHOLIS) and regional databases (inception until 16 December 2024) were searched to identify studies of interventions to optimize antibiotic use in children in LMIC peripheral healthcare settings.
Our search identified 7154 articles post de-duplication; 23 studies met the inclusion and Integrated quality Criteria for the Review of Multiple Study designs (ICROMS) assessment criteria. Seventeen were randomized trials, conducted in five LMICs, four upper-middle income countries (UMICs) and two low-income countries (LICs). Single-intervention studies investigated electronic algorithms (n = 3) and point-of-care tests (POCTs) (n = 4). Electronic algorithms and enhanced POCTs reduced antibiotic prescriptions for children with acute illness at primary care facilities in Tanzania. C-reactive protein POCTs achieved modest reductions in antibiotic prescribing for children in Vietnam and Uganda but not for those with febrile illness in Myanmar and Thailand. A diagnostic tool algorithm showed reduction of antibiotic prescriptions in Ghana and Burkina Faso, but not in Uganda.
Initial evidence suggests that algorithmic decision-support tools combined with point-of-care diagnostics and provider education can reduce antibiotic prescribing in children attending ambulatory healthcare settings in LMICs, with most studies demonstrating no compromise of clinical outcomes. However, few studies assessed prescription appropriateness or microbiological outcomes, limiting conclusions about long-term impact. Future interventions should prioritize context-adaptable strategies that incorporate rapid diagnostics, evaluate clinical and appropriateness outcomes, and consider implementation feasibility across diverse LMIC settings.
Estimating the Value of Novel Tests for Active Syphilis in Zimbabwe: How Much Overtreatment Can Be Avoided?
Stuart RM, Marks M, Chikwari CD, Muellenmeister AM, Abeysuriya RG, Manguro G, Peters RPH, Rao DW, Newman LM · Sex Transm Dis (2026)
Zimbabwe · DOI: 10.1097/OLQ.0000000000002348
Syphilis diagnosis in resource-limited settings relies on syndromic management and treponemal-based antibody screening tests that cannot distinguish active infection from past-treated infection, both of which can lead to overtreatment. Point-of-care (POC) tests that detect active infection could reduce unnecessary treatment.
We developed an agent-based model of co-transmitting syphilis and human immunodeficiency virus, calibrated to Zimbabwe using population-based survey data (ZIMPHIA) and UNAIDS estimates. We modeled five scenarios involving two hypothetical new POC diagnostic products introduced from 2027: (1) a test detecting Treponema pallidum DNA in genital ulcer specimens, and (2) a non-treponemal test identifying active infection following a treponemal-positive result, applied across antenatal care, key population, and human immunodeficiency virus care settings. We also conducted a threshold-based cost analysis to assess whether reductions in unnecessary treatment alone could be cost-saving.
Under the current standard of care, approximately 112,000 adult syphilis treatments are administered annually across all modeled detection and screening use cases, of which approximately 80% are unnecessary (i.e., administered to individuals who do not have an active syphilis infection). Combining both diagnostics reduces overtreatment to 24% (a 3.4-fold reduction). Across use cases, each test avoids approximately 0.4 to 0.8 unnecessary treatments, implying cost savings whenever the test price is less than 40% to 80% of the treatment cost.
Even under the conservative assumption that current syndromic management and screening practices achieve high syphilis treatment rates among care-seeking individuals, introducing POC diagnostics for active syphilis could substantially reduce overtreatment while maintaining treatment of individuals with active infection. Reductions in unnecessary treatment alone may be cost-saving at low test prices, even without accounting for downstream health outcomes. This analysis does not model the impact of improved diagnostics on transmission dynamics, congenital syphilis burden, or other health outcomes; studies that quantify these additional benefits are needed to inform a full economic evaluation.
Phylo-Plex: a phylogenetically informed, low-cost amplicon sequencing platform for deployable high-resolution genomic epidemiology.
Beale MA, Shetty V, Ambridge KE, Lacey G, Dougan S, Roberts-Sengier W, Sampher B, Lassalle F, Dorman MJ, Mahlangu MP, Venter JME, Da Costa Dias B, Chipinduro M, Washaya TM, Rodgers L, Makamure B, Dauya E, Marks M, Müller EE, Ferrand RA, Thomson NR · Nat Commun (2026)
Zimbabwe · DOI: 10.1038/s41467-026-75002-y
Genomic pathogen surveillance is a powerful tool for public health and research, but is costly and unachievable in low-resource settings. Most sub-genomic typing methods sacrifice resolution whilst remaining costly. We developed "Phylo-Plex", a novel approach that identifies information-rich genomic regions to maximise phylogenetic information whilst minimising the number of regions. Applied to Treponema pallidum and Neisseria gonorrhoeae, we designed a high-resolution multiplex PCR sequencing scheme for lineage tracking pathogens with different extremes of genome variation. For Treponema pallidum, we also designed and evaluated the Phylo-Plex scheme in the laboratory and field settings by sequencing 72 clinical samples using MinION Flongle cells. Our T. pallidum scheme comprising 59 multiplex amplicons achieved high discrimination of fine-scale sublineages comparable to those defined using whole genomes, and demonstrating a qPCR detection limit ≤Ct 32. Variant calls from MinION amplicon sequencing were highly correlated with Illumina whole genome sequencing. We successfully deployed the method in a low-resource laboratory in Zimbabwe, costed at <£300/24 samples (£12.47/sample). Phylo-Plex enables low-cost tracking of priority pathogenic lineages in low resource settings and at scale.
Does AMR surveillance of surface water reflect AMR in humans? A genomic comparison of ESBL-producing Escherichia coli from surface water, healthy residents, and a clinical facility.
Ayukafangha E, Mbanga J, Ismail A, Essack SY, Abia ALK · Environ Res (2026)
Zimbabwe · DOI: 10.1016/j.envres.2026.125249
Wastewater antimicrobial resistance (AMR) surveillance is limited in many low- and middle-income countries where wastewater infrastructure is absent or inadequate. Surface water may provide an alternative for AMR surveillance in such settings. We investigated the resistome, virulome, and phylogenetic relationships of ESBL-producing Escherichia coli (ESBL-Ec) from surface water (SW), healthy residents (HR), and a clinical facility (CL) to determine whether SW isolates reflect human-associated AMR. During an eight-month longitudinal study in South Africa, 95 ESBL-Ec isolates (SW = 32, HR = 32, CL = 31) underwent whole-genome sequencing. Bioinformatics was used to characterise antimicrobial resistance genes (ARGs), virulence genes, sequence types (STs), phylogroups, and phylogenetic relationships. Seven phylogroups and 21 STs were identified. Phylogroups A, B1, and D and STs 10 and 38 occurred across all sources. Several clinically important lineages, including ST131, were shared between SW and HR isolates; no ST was unique to clinical isolates. Phylogenetic analysis revealed predominantly ST-driven clustering, with SW isolates showing greater similarity to HR isolates than to clinical isolates. Forty-five ARGs were detected, including 12 β-lactamase genes. blaCTX-M-15 was the dominant ESBL gene in all clinical isolates and in approximately half of SW and HR isolates. Resistance and virulence gene profiles were more frequently shared between SW and HR than between SW and CL isolates. Surface water did not fully reflect community and clinical ESBL-Ec populations but captured clinically relevant lineages and resistance determinants. These findings support SW monitoring as a complementary AMR surveillance approach in resource-limited settings lacking wastewater infrastructure.
Ex Situ Diversity of Sorghum bicolor (L.) moench collections and derived wide crosses (sorghum x maize) based on DArTSeq markers.
Kaweesi T, Bombom A, Mcebisi M, Asiimwe P, Ovuga E · BMC Genomics (2026)
Zimbabwe · DOI: 10.1186/s12864-026-13162-3
Sorghum is an important crop in sub-Saharan Africa sustaining many livelihoods. However, despite its importance, sorghum continues to have limited research attention and priority and is categorized as one of the Neglected and Underutilised Species. The paucity of current information on genetic diversity and structure of sorghum accessions being cultivated, improved, introduced, and or conserved across east and southern Africa remains limited. Ex situ genetic diversity and population structure for 177 sorghum accessions from diverse sources was studied using high throughput Diversity Array Technology markers. A total of 15,220 DArTseq SNP markers were generated with over 90% call rate and 95% reproducibility. DArTseq SNP markers had an average polymorphic information content of 0.21 indicating the discriminatory power of DArTSeq markers. Genetic relationships estimated using discriminant analysis of principal components and ancestry coefficients revealed eight populations. Observed heterozygosity was lower than the expected heterozygosity across populations with a mean inbreeding coefficient (FIS) of 0.82. Analysis of molecular variance found 83% of the variation to be attributed to within-population variance. A high divergence (Fst = 0.16) obtained from AMOVA suggests high genetic differentiation among populations. Genetic diversity indices Shannon-wiener index (H) (3.37-3.95), Stoddard and Taylor index (G) (29-52) and Simpson's index (λ - Lambda) (0.90-0.99) were high across populations. Nei's unbiased gene diversity ranged from 0.13 to 0.23. The results suggest a high differentiation among sorghum accessions under study. Implications with respect to insights to guide identification, selection and testing of plant genetic resources for food and agriculture with unique genes and traits to address demand-led crop improvement and market needs, conservation, and deployment in farmer fields are shared.